drugset
Drugs / Engineered cartilage graft
last change Jul 2025 re-read 3 minutes ago

Engineered cartilage graft

also known as N-TEC

Cell therapy

Developed for
osteoarthritis, knee
Investigated by
Angry@Arthritis · Clinical Trial Unit, University Hospital Basel, Switzerland · European Union · Foundation National Reumafonds · Geistlich Pharma AG · Maastricht University
+8 more · Medical University of Vienna · Promove-Biotec GmbH · Theracell Laboratories · University Hospital, Basel, Switzerland · University of Miami · University of Oulu · Videoreha · Wuerzburg University Hospital

Trials 1

today NCT06576583 · Ph 2
2026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06576583 Jul 2025 → Jan 2029 expected osteoarthritis, knee University Hospital, Basel, Switzerland Recruiting No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Engineered cartilage graft “Engineered cartilage graft (N-TEC)” NCT06576583 ↗
Known as N-TEC ClinicalTrials.gov intervention name — accepted as the source's own label NCT06576583 ↗
Action Restore “mode of action, which is expected to be of regenerative nature” NCT06576583 ↗
Modality Cell therapy “autologous nasal chondrocytes” NCT06576583 ↗
Route Other “The IMP is implanted in the knee at the patellofemoral joint.” NCT06576583 ↗